DDReg pharma

Quailty Driven by Passion

Submit Query

Blogs

Home » Blogs » Page 6
Role of Blockchain and IoT in Drug Development.

Evaluating the Role of Blockchain and IoT in Drug Development

All Category, Blogs /

The pharmaceutical industry is undergoing a significant transformation, driven by the need for innovation and efficiency in pharmaceutical drug development. Drug development is a resource-intensive process that can take 10–15 years and cost billions of dollars to bring a medicine to market. One important aspect is the clinical trials, which face many challenges, including data […]

Evaluating the Role of Blockchain and IoT in Drug Development Read More »

South Koreas Regulatory Landscape for drugs

Navigating the Drug Regulatory Landscape of South Korea

All Category, Blogs /

With its rapidly growing pharmaceutical industry and stringent regulatory requirements, South Korea is becoming a key global player. But for pharmaceutical companies, navigating this landscape requires strategic planning and compliance expertise.  The Ministry of Food and Drug Safety in South Korea (MFDS), previously known as the Korean Food and Drug Administration, serves as South Korea’s

Navigating the Drug Regulatory Landscape of South Korea Read More »

pharmacovigilance approach for biosimilars market

Pharmacovigilance Approaches for Biosimilars Market Success 

All Category, Blogs, Pharmacovigilance /

The pharmaceutical field has witnessed a tremendous growth of innovation and success in the past few years. Among these advancements, biosimilars have become essential for improving patient access and reducing the cost of therapies. The complexities that even a slight manufacturing differences can lead to variations in protein structure, post-translational modifications, and glycosylation patterns. Since

Pharmacovigilance Approaches for Biosimilars Market Success  Read More »

Global Cosmetic Regulations A Guide for Cometic Products

Understanding Global Cosmetic Regulatory Standards

All Category, Blogs /

The global cosmetic industry is a complex and rapidly growing landscape where regulatory compliance is fundamental in ensuring product safety, efficacy, and market access. As cosmetic products cross borders, manufacturers must comply with country-specific regulations from ingredients safety to product labeling. These regulations protect consumers and set the standards that businesses must follow to enter

Understanding Global Cosmetic Regulatory Standards Read More »

Outsourcing MAH

How Does Outsourcing MAH Responsibilities Impact a Pharmaceutical Company’s Global Expansion Strategy?

All Category, Blogs /

Marketing Authorisation Holder (MAH) refers to a person or company that has been granted permission to market a pharmaceutical product within a specific country. MAHs are subject to a number of regulatory requirements and ensure pharmaceutical products meet stringent safety and quality standards. As regulatory frameworks are becoming more stringent, many companies are turning to

How Does Outsourcing MAH Responsibilities Impact a Pharmaceutical Company’s Global Expansion Strategy? Read More »

Digital Revolution on Pharmaceutical Industry

Impact of the Digital Revolution on Pharmaceutical Industry

All Category, Blogs /

The pharmaceutical industry, long characterized by traditional research and manufacturing practices, is currently undergoing a profound revolution. Led by advanced analytics, artificial intelligence (AI), blockchain, and other cutting-edge technologies, digital innovations are revolutionizing drug discovery, manufacturing, marketing patient care services and regulatory oversight, with real world examples and extensive research supporting these changes. This blog

Impact of the Digital Revolution on Pharmaceutical Industry Read More »

Veterinary Regulations

Navigating Challenges and Future Opportunities in Veterinary Regulations

All Category, Blogs /

The field of veterinary medicine is rapidly advancing, driven by new therapies and technologies as well as increasing public health concerns about antimicrobial resistance (AMR). Regulatory agencies around the world–such as FDA, EMA and regional bodies–are adapting quickly to these changes, with regulatory frameworks constantly adapting to ensure veterinary medicinal products (VMPs) meet stringent safety

Navigating Challenges and Future Opportunities in Veterinary Regulations Read More »

Malaysia Pharmaceutical Regulatory Pathway

Understanding the Pharmaceutical Regulatory Landscape of Malaysia

All Category, Blogs /

Malaysia’s pharmaceutical industry is a rapidly growing sector, driven by increasing healthcare demands, advancements in medical research, and government support. For pharmaceutical companies looking to enter the Malaysian market, understanding the regulatory framework is crucial. The National Pharmaceutical Regulatory Agency (NPRA) plays a key role in overseeing drug approvals, quality standards, and compliance with national

Understanding the Pharmaceutical Regulatory Landscape of Malaysia Read More »

Registered Products in USA through Pharma Regulatory Consultant

How Pharmaceutical Regulatory Consultant Helps Product Registration in the USA

All Category, Blogs /

The pharmaceutical regulatory consultants are specialists in FDA regulations and can guide companies through the registration process for their products making sure that all the required documentation, clinical data, and measures to ensure compliance are in the correct order. Over the decades, the regulatory framework in the United States has advanced and driven by scientific

How Pharmaceutical Regulatory Consultant Helps Product Registration in the USA Read More »

PRIME vs. EU pathways: Strategy, global impact, and drug development insights

Comparing PRIME and EU Pathways: Long -Term Strategy and Global Impact

All Category, Blogs /

In the European Union (EU), the European Medicines Agency (EMA) has implemented several expedited regulatory pathways, notably the PRIority MEdicines (PRIME) scheme, to facilitate the development and approval of promising medicines. Launched in March 2016, the PRIME scheme aims to enhance support for the development of medicines that target an unmet medical need. In addition

Comparing PRIME and EU Pathways: Long -Term Strategy and Global Impact Read More »